Study guide

Cirrhosis diagnosis and prognosis

AMC CAT MCQ Examination AMC Part 1

Track your progress as you read

Finished sections get a check mark.

1 Acute Coronary Syndromes & ECG Localization

ACS recognition and ECG localisation Reperfusion and infarction complications

2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias

Heart failure assessment and treatment Arrhythmias and conduction emergencies

3 Systemic Hypertension & Peripheral Vascular Disease

Blood pressure and cardiovascular risk Secondary hypertension and arterial disease

4 Valvular Heart Disease, Infective Endocarditis & Pericarditis

Aortic and mitral valve disease Endocarditis and pericardial emergencies

5 Asthma & COPD Acute Flares and Maintenance

Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations

6 Pneumonia, pleural disease and respiratory failure

Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis

7 GI bleeding, bowel inflammation and malabsorption

GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS

8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis

Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance

9 Diabetes, thyroid and adrenal disease

Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease

10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies

AKI and chronic kidney disease Potassium and sodium emergencies

11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment

Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care

12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis

Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia

13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology

Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms

14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis

Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment

15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries

Trauma primary survey and adjuncts Chest trauma and immediate threats

16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance

Head injury, imaging and haemorrhage Herniation and spinal cord injury

17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome

Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury

18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care

Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus

19 Aortic Aneurysms & Acute Arterial Limb Ischaemia

Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia

20 Urological Emergencies, Testicular Torsion & Haematuria Investigation

Retention, stones and obstructed infection Scrotal pain and haematuria

21 Preoperative Risk Stratification & Postoperative Surgical Complications

Preoperative assessment and medicines Postoperative complications and prevention

22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening

Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons

23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy

Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding

24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies

Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth

25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis

Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care

26 Contraception, Emergency Contraception & Pregnancy Termination

Contraceptive choice and missed pills Emergency contraception and abortion

27 Australian Cervical Screening Program & Gynaecological Malignancies

Cervical screening and cervical cancer Endometrial and ovarian cancer

28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice

Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening

29 Developmental Milestones, Growth Charts & Failure to Thrive

Developmental milestones Regression, autism and support Faltering growth and developmental comparisons

30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions

Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons

31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis

Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis

32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease

Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up

33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury

Pyloric stenosis Intussusception and dehydration Child protection and injury assessment

34 The Mental State Examination & Suicide Risk Stratification

Mental state examination and psychotic symptoms Suicide formulation and mental health law

35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers

Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT

36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder

Anxiety, panic and agoraphobia OCD and trauma-related disorders

37 Schizophrenia, Acute Psychosis & Antipsychotic Management

Psychosis assessment and antipsychotics Clozapine and severe adverse effects

38 Substance Use Disorders & Acute Withdrawal Syndromes

Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants

39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry

Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry

40 Medicare, PBS, AHPRA & Good Medical Practice Framework

Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications

41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment

Consent, material risks and young people Capacity, refusal and substitute decisions

42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications

Privacy, disclosure and child reporting Driving fitness and threat disclosure

43 First Nations health and preventive care

First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention

44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases

Epidemiology, calculations, bias and surveillance

45 Neurological presentations

Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness

46 Musculoskeletal pain

Back, neck, bone and soft tissue pain

47 Eye presentations

Altered vision and retinal disease Red eye, ocular injury and discharge

48 Ear, nose, throat and oral health

Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis

49 Skin, hair and nails

Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities

50 Breast health and feeding

Breast lumps, discharge and breastfeeding problems

51 Sexual and reproductive presentations

Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction

52 Palliative care and carers

The dying patient, symptoms and carers

53 Eating disorders and personality care

Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care

54 Sleep presentations

Insomnia, snoring and daytime sleepiness

55 Poisoning, resuscitation and environmental emergencies

Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning

56 Communication, rights and professional practice

Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health

57 Genetics, research and donation

Genetic testing, research and organ donation

58 Travel, fever and outbreaks

Fever, travellers and outbreak response

Cirrhosis diagnosis and prognosis

Key Takeaways Explain This Topic AI

Child-Pugh uses bilirubin, albumin, INR, ascites and encephalopathy.

MELD-based assessment supports prognosis and transplant evaluation.

A prognostic score should not by itself establish that treatment is futile.

Last updated: October 2026

Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis

Chronic liver disease (CLD) and cirrhosis represent significant contributors to morbidity and mortality in Australia. Cirrhosis is the histopathological end-stage of chronic necroinflammatory liver injury, characterized by diffuse replacement of normal hepatic architecture with fibrotic regenerative nodules and altered intrahepatic vascular resistance. Decompensation marks the transition from a stable asymptomatic state to high-mortality clinical failure.

  • Cirrhosis Aetiologies & Pathophysiology
  • Primary Aetiologies in Australia

Alcohol-related disease: Ask about quantities in Australian standard drinks, duration and dependence without treating a grams-per-day cut-off as a safe level. Liver risk depends on multiple factors. Abstinence is recommended with established alcohol-related liver disease, with withdrawal risk addressed safely.

Metabolic Dysfunction-Associated Steatohepatitis (MASH): Formerly termed non-alcoholic steatohepatitis (NASH). Driven by metabolic syndrome, insulin resistance, type 2 diabetes mellitus, dyslipidaemia, and obesity. Histology shows ballooned hepatocytes, Mallory-Denk bodies, and pericellular 'chicken-wire' fibrosis.

Chronic Viral Hepatitis (HBV & HCV): Non-cytopathic viral persistence causing immune-mediated hepatocyte destruction and progressive fibrogenesis.

Autoimmune & Cholestatic Liver Diseases:

Autoimmune Hepatitis (AIH): Interface hepatitis with prominent plasma cell infiltration, elevated serum IgG, and autoantibodies (anti-nuclear antibody [ANA], anti-smooth muscle antibody [ASMA], anti-liver kidney microsomal-1 [anti-LKM1]).

Primary Biliary Cholangitis (PBC): T-cell mediated autoimmune destruction of small intrahepatic interlobular bile ducts occurring primarily in middle-aged women. Characterised by raised alkaline phosphatase (ALP), antimitochondrial antibody (AMA) positivity in > 95 % > 95\% > 95% , and elevated serum IgM.

Primary Sclerosing Cholangitis (PSC): Fibro-obliterative destruction of medium and large intra- and extrahepatic bile ducts strongly linked to inflammatory bowel disease ( 70 − 80 % 70-80\% 70 − 80% have ulcerative colitis). Leads to multifocal strictures ('beading') on MRCP.

Genetic & Metabolic Infiltration:

Hereditary Haemochromatosis: Autosomal recessive HFE gene mutation (C282Y homozygosity), causing unregulated intestinal iron absorption and parenchymal iron deposition. Screened via transferrin saturation ( > 45 − 50 % > 45-50\% > 45 − 50% ) and serum ferritin.

Wilson Disease: Autosomal recessive ATP7B mutation causing impaired biliary copper excretion. Presents in adolescents or young adults with acute hepatitis, cirrhosis, Kayser-Fleischer rings, and basal ganglia neuropsychiatric symptoms. Low serum caeruloplasmin and elevated 24-hour urinary copper.

Alpha-1 Antitrypsin Deficiency: SERPINA1 gene mutation (PiZZ phenotype); misfolded glycoprotein aggregates within hepatocyte endoplasmic reticulum (PAS-positive, diastase-resistant globules), predisposing to cirrhosis and panacinar emphysema.

Pathophysiological Cascade of Portal Hypertension

Normal hepatic venous pressure gradient (HVPG) is 1 − 5 mmHg 1-5\text{ mmHg} 1 − 5 mmHg . Clinically significant portal hypertension (CSPH) develops when H V P G ≥ 10 mmHg HVPG \ge 10\text{ mmHg} H V PG ≥ 10 mmHg :

Increased Intrahepatic Resistance: Structural distortion from collagen deposition in the space of Disse plus functional vasoconstriction driven by decreased endothelial nitric oxide (NO) synthase activity.

Splanchnic Arterial Vasodilation: Splanchnic endothelial release of endogenous vasodilators (predominantly nitric oxide) leads to massive splanchnic arterial vasodilation.

Hyperdynamic Circulation & Neurohormonal Activation: Pooling of blood in the splanchnic bed causes a decrease in effective arterial blood volume (EABV) . Baroreceptors sense arterial underfilling, triggering intense activation of the renin-angiotensin-aldosterone system (RAAS) , sympathetic nervous system (SNS) , and non-osmotic release of arginine vasopressin (ADH) .

Fluid Retention: Sustained renal sodium and water retention causes plasma volume expansion, elevating portal inflow and perpetuating ascites, variceal enlargement, and circulatory collapse.

Clinical Prognostic Scoring Systems

Risk stratification directs transplant assessment and monitors disease progression.

The Child-Turcotte-Pugh (CTP) Score

The Child-Pugh score evaluates five clinical and laboratory parameters, each assigned 1, 2, or 3 points:

Total Bilirubin : 1 Point: < 34 μ mol/L < 34\ \mu\text{mol/L} < 34 μ mol/L ; 2 Points: 34 − 50 μ mol/L 34-50\ \mu\text{mol/L} 34 − 50 μ mol/L ; 3 Points: > 50 μ mol/L > 50\ \mu\text{mol/L} > 50 μ mol/L

Serum Albumin : 1 Point: > 35 g/L > 35\text{ g/L} > 35 g/L ; 2 Points: 28 − 35 g/L 28-35\text{ g/L} 28 − 35 g/L ; 3 Points: < 28 g/L < 28\text{ g/L} < 28 g/L

INR : 1 Point: < 1.7 < 1.7 < 1.7 ; 2 Points: 1.7 − 2.3 1.7-2.3 1.7 − 2.3 ; 3 Points: > 2.3 > 2.3 > 2.3

Ascites : 1 Point: Absent; 2 Points: Mild / Controlled by diuretics; 3 Points: Moderate to severe / Refractory

Grade 1: Subtle attention, personality or sleep changes; clear asterixis is more typical of grade 2. Exclude infection, medicines, glucose/electrolyte disturbance and intracranial disease.

Child-Pugh Class A (5 to 6 points): Well-compensated disease. 1-year survival approximately 100 % 100\% 100% .

Child-Pugh Class B (7 to 9 points): Significant functional compromise. 1-year survival approximately 80 % 80\% 80% .

Child-Pugh Class C (10 to 15 points): Decompensated cirrhosis. 1-year survival approximately 45 % 45\% 45% ; urgent referral for liver transplantation evaluation required.

The Model for End-Stage Liver Disease (MELD) Score

MELD is a validated mathematical model predicting 90-day mortality based on objective objective variables:

  • Serum Bilirubin
  • Serum Creatinine
  • INR
  • Serum Sodium (MELD-Na)

Used across Australian liver transplant centers to prioritize deceased donor organ allocation based on medical urgency rather than waiting time.

Prognosis is not a fixed prediction

A person with ascites, low albumin and a raised INR needs assessment of decompensation, reversible triggers and suitability for transplant referral. Calculate the score from the actual components and check whether anticoagulants or other factors confound them. A prognostic category describes risk in populations; it does not give an exact remaining lifespan or establish that treatment is futile. Reassess nutrition, alcohol dependence, infection risk and follow-up access. A patient who improves after treating the cause can still need surveillance for complications.

Primary references (checked 7 October 2026): ADQI–ICA cirrhosis/AKI consensus .

Sections you finish are checked off in the contents.

  • Up Next
  • Decompensation, viral hepatitis and surveillance
  • Continue learning